Area of expertise: Antibacterial drug resistance mechanisms

Alex O’Neill

Alex O’Neill

Professor
University of Leeds
more
Malcolm Page

Malcolm Page

Formerly Roche, Switzerland
more
Michael Pucci

Michael Pucci

Executive Director, Early Drug Discovery
Spero Therapeutics
more
Daniel Ritz

Daniel Ritz

Senior Director and Senior Group Leader
Idorsia Pharmaceuticals
more
Carole Sable

Carole Sable

Principle
CA Sable Consulting, LLC
more
William Shafer

William Shafer

Professor of Microbiology and Immunology
Emory University School of Medicine
more
Nusrat Shafiq

Nusrat Shafiq

Professor
Postgraduate Institute of Medical Education and Research
more
Ed Siegwart

Ed Siegwart

Director of Microbiology
Oppilotech Ltd
more
Lynn L. Silver

Lynn L. Silver

LL Silver Consulting
more
David A. Six

David A. Six

Principal Scientist
Venatorx Pharmaceuticals
more

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletter

Go to Top